These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
424 related articles for article (PubMed ID: 11430614)
1. Serotonergic and noradrenergic reuptake inhibitors: prediction of clinical effects from in vitro potencies. Frazer A J Clin Psychiatry; 2001; 62 Suppl 12():16-23. PubMed ID: 11430614 [TBL] [Abstract][Full Text] [Related]
2. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites. Béïque JC; de Montigny C; Blier P; Debonnel G Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630 [TBL] [Abstract][Full Text] [Related]
3. Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors. Dekeyne A; Gobert A; Auclair A; Girardon S; Millan MJ Psychopharmacology (Berl); 2002 Jul; 162(2):156-67. PubMed ID: 12110993 [TBL] [Abstract][Full Text] [Related]
4. Duloxetine pharmacology: profile of a dual monoamine modulator. Karpa KD; Cavanaugh JE; Lakoski JM CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192 [TBL] [Abstract][Full Text] [Related]
5. Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test. O'Leary OF; Bechtholt AJ; Crowley JJ; Hill TE; Page ME; Lucki I Psychopharmacology (Berl); 2007 Jun; 192(3):357-71. PubMed ID: 17318507 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Sánchez C; Hyttel J Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421 [TBL] [Abstract][Full Text] [Related]
10. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex. Felton TM; Kang TB; Hjorth S; Auerbach SB Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903 [TBL] [Abstract][Full Text] [Related]
11. Noradrenergic versus serotonergic antidepressants: predictors of treatment response. Schatzberg AF J Clin Psychiatry; 1998; 59 Suppl 14():15-8. PubMed ID: 9818626 [TBL] [Abstract][Full Text] [Related]
12. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition. Jones CK; Eastwood BJ; Need AB; Shannon HE Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620 [TBL] [Abstract][Full Text] [Related]
13. Is there a role for a pure noradrenergic drug in the treatment of depression? Montgomery SA Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305 [TBL] [Abstract][Full Text] [Related]
14. Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor. Wong EH; Sonders MS; Amara SG; Tinholt PM; Piercey MF; Hoffmann WP; Hyslop DK; Franklin S; Porsolt RD; Bonsignori A; Carfagna N; McArthur RA Biol Psychiatry; 2000 May; 47(9):818-29. PubMed ID: 10812041 [TBL] [Abstract][Full Text] [Related]
15. SSRIs and SNRIs: broad spectrum of efficacy beyond major depression. Gorman JM; Kent JM J Clin Psychiatry; 1999; 60 Suppl 4():33-8; discussion 39. PubMed ID: 10086481 [TBL] [Abstract][Full Text] [Related]
16. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. Beyer CE; Boikess S; Luo B; Dawson LA J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]